ℹ️ Compiled from public regulatory records · Last regulator revision: March 22, 2025🚩 Report this page
Peramivir
Neuraminidase Inhibitors
Sold as RAPIVAB
CA Health Canada
- Drug class
- Neuraminidase Inhibitors
- Availability
- See label
- Routes
- Intravenous
- Markets covered
- 1
- Products on record
- 1
Overview
Peramivir is an active pharmaceutical ingredient in the Neuraminidase Inhibitors group (J05AH). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | March 22, 2025 |
CACanada· Health Canada
1 product
Uses
AND CLINICAL USE
Who should not take it
Sources & citations
- [1]Health Canada (DPD) · 02460319 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.